98 related articles for article (PubMed ID: 15113364)
1. Empirical use of antisecretory drug therapy delays diagnosis of upper gastrointestinal adenocarcinoma but does not effect outcome.
Panter SJ; O'Flanagan H; Bramble MG; Hungin AP
Aliment Pharmacol Ther; 2004 May; 19(9):981-8. PubMed ID: 15113364
[TBL] [Abstract][Full Text] [Related]
2. Delays in diagnosis and therapy of gastric cancer and esophageal adenocarcinoma.
Witzig R; Schönberger B; Fink U; Busch R; Gundel H; Sendler A; Peschel C; Siewert JR; Lordick F
Endoscopy; 2006 Nov; 38(11):1122-6. PubMed ID: 17111334
[TBL] [Abstract][Full Text] [Related]
3. Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy.
Bramble MG; Suvakovic Z; Hungin AP
Gut; 2000 Apr; 46(4):464-7. PubMed ID: 10716673
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of alarm symptoms in patients with gastric cancer.
Stephens MR; Lewis WG; White S; Blackshaw GR; Edwards P; Barry JD; Allison MC
Br J Surg; 2005 Jul; 92(7):840-6. PubMed ID: 15892157
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma.
Scott LC; Yao JC; Benson AB; Thomas AL; Falk S; Mena RR; Picus J; Wright J; Mulcahy MF; Ajani JA; Evans TR
Cancer Chemother Pharmacol; 2009 Jan; 63(2):363-70. PubMed ID: 18398613
[TBL] [Abstract][Full Text] [Related]
6. Response to definitive chemoradiotherapy and survival in patients with an oesophageal adenocarcinoma versus squamous cell carcinoma: a matched-pair analysis.
Tougeron D; Di Fiore F; Hamidou H; Rigal O; Paillot B; Michel P
Oncology; 2007; 73(5-6):328-34. PubMed ID: 18497505
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of exacerbating gastrointestinal disease among elderly patients following treatment with calcium channel blockers.
Hamada A; Ishii J; Doi K; Hamada N; Miyazaki C; Hamada T; Ohwaki Y; Wada M; Nakashima K
J Clin Pharm Ther; 2008 Dec; 33(6):619-24. PubMed ID: 19138239
[TBL] [Abstract][Full Text] [Related]
8. Influence of calcium channel blockers in patients with gastrointestinal disease in Japanese community pharmacies.
Hamada A; Akiyoshi R; Ishii J; Hamada N; Miyazaki C; Hamada T; Ohwaki Y; Ikeda R; Wada M; Nakashima K
J Clin Pharm Ther; 2012 Feb; 37(1):74-7. PubMed ID: 21395634
[TBL] [Abstract][Full Text] [Related]
9. Antacid drug use and risk of esophageal and gastric adenocarcinomas in Los Angeles County.
Duan L; Wu AH; Sullivan-Halley J; Bernstein L
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):526-33. PubMed ID: 19190141
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for gastro-oesophageal reflux disease symptoms: a community study.
Mohammed I; Nightingale P; Trudgill NJ
Aliment Pharmacol Ther; 2005 Apr; 21(7):821-7. PubMed ID: 15801917
[TBL] [Abstract][Full Text] [Related]
11. The outcome of patients with remnant primary gastric cancer compared with those having upper one-third gastric cancer.
An JY; Choi MG; Noh JH; Sohn TS; Kim S
Am J Surg; 2007 Aug; 194(2):143-7. PubMed ID: 17618792
[TBL] [Abstract][Full Text] [Related]
12. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
13. Clinical profile of carcinoma stomach at a tertiary care hospital in south India.
Sambasivaiah K; Ibrarullah M; Reddy MK; Reddy PV; Wagholikar G; Jaiman S; Reddy DG; Sarma KV; Hegde GN
Trop Gastroenterol; 2004; 25(1):21-6. PubMed ID: 15303466
[TBL] [Abstract][Full Text] [Related]
14. Clinical and financial outcomes associated with a proton pump inhibitor prior-authorization program in a Medicaid population.
Delate T; Mager DE; Sheth J; Motheral BR
Am J Manag Care; 2005 Jan; 11(1):29-36. PubMed ID: 15697098
[TBL] [Abstract][Full Text] [Related]
15. Outcome of oesophagectomy for adenocarcinoma of the oesophagus and oesophagogastric junction.
Zhang X; Watson DI; Jamieson GG; Lally C; Bessell JR; Devitt PG
ANZ J Surg; 2005 Jul; 75(7):513-9. PubMed ID: 15972033
[TBL] [Abstract][Full Text] [Related]
16. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
17. Endoscopy waiting times and impact of the two week wait scheme on diagnosis and outcome of upper gastrointestinal cancer.
Spahos T; Hindmarsh A; Cameron E; Tighe MR; Igali L; Pearson D; Rhodes M; Lewis MP
Postgrad Med J; 2005 Nov; 81(961):728-30. PubMed ID: 16272239
[TBL] [Abstract][Full Text] [Related]
18. Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends.
Cooper GS; Kou TD; Chak A
Am J Gastroenterol; 2009 Jun; 104(6):1356-62. PubMed ID: 19491849
[TBL] [Abstract][Full Text] [Related]
19. The impact on survival of thromboembolic phenomena occurring before and during protocol chemotherapy in patients with advanced gastroesophageal adenocarcinoma.
Tetzlaff ED; Correa AM; Baker J; Ensor J; Ajani JA
Cancer; 2007 May; 109(10):1989-95. PubMed ID: 17397035
[TBL] [Abstract][Full Text] [Related]
20. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
